Central neurocytoma responsive to topotecan, ifosfamide, carboplatin

Pediatr Blood Cancer. 2008 Jul;51(1):137-40. doi: 10.1002/pbc.21551.

Abstract

A 5-year-old male presented with spinal cord drop metastasis from a recurrent neurocytoma. Topotecan (0.5 mg/m(2)) and carboplatin (250 mg/m(2)) were administered on days 1-3 and ifosfamide (1,800 mg/m(2)) on days 1-5, every 21 days, for three cycles and resulted in complete response without severe complications. A literature review yielded 20 patients with central neurocytoma but no complete responses. The complete response of central neurocytoma to chemotherapy only reported here should be helpful to those caring for patients with this rare tumor.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carboplatin
  • Child, Preschool
  • Disease-Free Survival
  • Humans
  • Ifosfamide
  • Magnetic Resonance Imaging
  • Male
  • Neurocytoma / diagnosis
  • Neurocytoma / drug therapy*
  • Remission Induction
  • Topotecan

Substances

  • Topotecan
  • Carboplatin
  • Ifosfamide